Advisory Services Network’s Niagen Bioscience NAGE Stock Holding History

Advisory Services Network’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42	Closed	-$185	–	4881
2026 Q1	$185	Buy	+42	New	+$227	﹤0.01%	4576
2025 Q4	–	Sell	-792	Closed	-$7.39K	–	4490
2025 Q3	$7.39K	Buy	+792	New	+$8K	﹤0.01%	3399
2018 Q2	–	Sell	-1,500	Closed	-$6K	–	2724
2018 Q1	$6K	Hold	1,500	–	–	﹤0.01%	2070
2017 Q4	$9K	Hold	1,500	–	–	﹤0.01%	1894
2017 Q3	$6K	Buy	+1,500	New	+$5.48K	﹤0.01%	1841

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Advisory Services Network's NAGE Position: Q2 2026 in Review

Advisory Services Network sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 42 shares — an estimated $185 sold.

Advisory Services Network first reported a position in NAGE in Q3 2017 and held it in 5 quarters. The position peaked at $9K in Q4 2017. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Advisory Services Network reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 42 Niagen Bioscience shares in Q2 2026, an estimated $185.
Advisory Services Network first reported a position in Niagen Bioscience in Q3 2017 and held it in 5 quarters.
Advisory Services Network's Niagen Bioscience position peaked at $9K in Q4 2017.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.